WHO slams US-funded newborn vaccine trial as “unethical”

“Exploiting scarcity is not ethical,” the WHO wrote in its statement today.

Dangerous trial

The United Nations health agency highlighted that the hepatitis B vaccine birth dose is “an effective, and essential public health intervention” that has “been used for over three decades, with more than 115 countries including it in their national schedules. “

“It prevents life‑threatening liver disease by stopping mother‑to‑child transmission at birth,” the WHO wrote, noting that more than 12 percent of adults in Guinea-Bissau have chronic hepatitis B.

In a section subtitled “Why withholding the vaccine is unethical,” the WHO lays out all the reasons the trial is dangerous.

“From what is publicly described, the

→ Continue reading at Ars Technica

Related articles

Comments

Share article

Latest articles